Evidence map›Paper›PMID 31454333›Full record

ArticleThe Journal of clinical investigation2019

Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm.

Michael Hugelshofer, Raphael M Buzzi, Christian A Schaer, Henning Richter, Kevin Akeret, Vania Anagnostakou, Leila Mahmoudi, Raphael Vaccani, Florence Vallelian, Jeremy W Deuel and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Scavenger endothelial cells alleviate tissue damage by engulfing toxic molecules derived from hemolysis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Haptoglobin Response after Aneurysmal Subarachnoid Haemorrhage.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

Michael HugelshoferDepartment of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Raphael M BuzziDivision of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
Christian A SchaerDivision of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
Henning RichterClinic for Diagnostic Imaging, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Kevin AkeretDepartment of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Vania AnagnostakouDepartment of Neuroradiology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Leila MahmoudiDivision of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
Raphael VaccaniDivision of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
Florence VallelianDivision of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
Jeremy W DeuelDivision of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
Peter W KronenVeterinary Anaesthesia Services - International, Winterthur, Switzerland.
Zsolt KulcsarDepartment of Neuroradiology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Luca RegliDepartment of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Jin Hyen BaekCenter of Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Ivan S PiresWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio, USA.
Andre F PalmerWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio, USA.
Matthias DennlerClinic for Diagnostic Imaging, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Rok HumarDivision of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
Paul W BuehlerCenter of Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Patrick R KircherClinic for Diagnostic Imaging, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Emanuela KellerNeurointensive Care Unit, University Hospital of Zurich, Zurich, Switzerland.
Dominik J SchaerDivision of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
University of Zurich · CHUniversity Hospital of Zurich · CHCenter for Biologics Evaluation and Research · USThe Ohio State University · USETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delayed ischemic neurological deficit (DIND) is a major driver of adverse outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH), defining an unmet need for therapeutic development. Cell-free hemoglobin that is released from erythrocytes into the cerebrospinal fluid (CSF) is suggested to cause vasoconstriction and neuronal toxicity, and correlates with the occurrence of DIND. Cell-free hemoglobin in the CSF of patients with aSAH disrupted dilatory NO signaling ex vivo in cerebral arteries, which shifted vascular tone balance from dilation to constriction. We found that selective removal of hemoglobin from patient CSF with a haptoglobin-affinity column or its sequestration in a soluble hemoglobin-haptoglobin complex was sufficient to restore physiological vascular responses. In a sheep model, administration of haptoglobin into the CSF inhibited hemoglobin-induced cerebral vasospasm and preserved vascular NO signaling. We identified 2 pathways of hemoglobin delocalization from CSF into the brain parenchyma and into the NO-sensitive compartment of small cerebral arteries. Both pathways were critical for hemoglobin toxicity and were interrupted by the large hemoglobin-haptoglobin complex that inhibited spatial requirements for hemoglobin reactions with NO in tissues. Collectively, our data show that compartmentalization of hemoglobin by haptoglobin provides a novel framework for innovation aimed at reducing hemoglobin-driven neurological damage after subarachnoid bleeding.

Indexed as

AnimalsBasilar ArteryBrainCerebrospinal FluidDisease Models, AnimalFemaleHaptoglobinsHemoglobinsHumansIntracranial AneurysmMaleMiceMice, Inbred C57BLProteomicsSheepSignal Transductionhaptoglobin-hemoglobin complexHaptoglobinsHemoglobinsCardiovascular diseaseNeuroscienceNitric oxideStrokeVascular Biology

Identifiers

PMID31454333
PMCPMC6877320
OpenAlexW2970013250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.